GENOSCIENCE PHARMA

Genoscience Pharma is a French biotech company developing unique small molecules in Oncology. This is the first clinical stage company ever with unique lysosomotropic agents assessed in a global clinical trial... Genoscience Pharma is committed to serving the needs of patients, families, and physicians by providing rapid access to the developed innovative therapeutic treatment. The following is the list of the current investigational programs currently in progress. Also listed below are the diseases targeted by our investigational programs... As all human living cells, cancer cells need energy to self-renew and survive. Lysosome is a key compartment implicated in cancer cells survival. Among the acquired modifications in cancer cells, changes in lysosomal phenotype and functions are well described, making lysosome a target of interest for novel therapies. Genoscience Pharma focuses on new approaches based on the depriving of cancer cells from essential nutrients by disrupting..

Primary location: Marseille France